logo
logo

Alterome Therapeutics Launches With $64M Series A Financing

Alterome Therapeutics Launches With $64M Series A Financing

01/19/22, 1:00 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan diego
Money raised
$64 million
Round Type
series a
Alterome Therapeutics, Inc., a biopharmaceutical company developing alteration-specific targeted therapies for the treatment of cancer, announced the closing of a $64M Series A financing. The financing was led by OrbiMed, with participation from Nextech Invest, Vida Ventures, Boxer Capital, and others. Alterome Therapeutics was co-founded by Eric Murphy, Ph.D., and Ryan Corcoran, M.D., Ph.D.

Company Info

Company
Alterome Therapeutics
Location
san diego, california, united states
Additional Info
Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. The company will be led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs.